Cost analysis of various branded versus generic chemotherapeutic agents used for the treatment of early breast cancer- a deep insight from India.

Background: Breast cancer (BC) stands first with high incidence and mortality in India. Most of the oncologists are unaware of cost savings by utilising generic drugs.

Aim: To perform a cost minimization analysis of generic versus branded chemotherapeutic regimen for treatment of BC.